fashion -WSS

fashion

author：hotspot 2025-10-01 14:19:57 - browse：129

Roche HQ — SEBASTIEN BOZON/AFP via Getty Images

The multibillion-dollar hunt for what many drugmakers hope will be the next big immunotherapy target has had no shortage of twists and tea-leaf-reading. In the wee hours of Wednesday morning, it got another.

Roche confirmed it accidentally released interim data from a closely watched clinical trial testing whether blocking that target — a protein on T cells known as TIGIT — can enable non-small lung cancer patients to live longer than standard immunotherapy alone.

The announcement release came hours after Evercore analyst Umer Raffat emailed investors that he had found a presentation on a Roche media portal, presumably uploaded by accident.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Why we need to separate burnout from moral injury in health care

leisure time

focus

WSS

ASCO eve: Let’s set the table for this year's meeting

Why we need to separate burnout from moral injury in health care

Ask STAT: What do you want to know about ChatGPT in medicine?

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Paxlovid study fails to answer questions over benefit for broader groups

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

focus

fashion

hotspot

Walensky prepares to leave CDC — and Congress — behind

Fentanyl is making it harder to start addiction treatment

Medicare proposal to cover medical devices draws a mixed reaction

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The battle over the Brookhaven Landfill on Long Island

In Memoriam: Notable people who died in 2023

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Alkermes shareholders re

STAT's guide to the next generation of CAR

knowledge

Addressing health care workers' trauma can help fight burnout

Liver decline slowed by off

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

UnitedHealth argues against case alleging wrongful AI care denials

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Study finds gene variants tied to breast cancer risk in Black women

entertainment

leisure time

focus

hotspot